// App-Quantinova.ai

TCT-178 : Everolimus-Eluting Stents versus Coronary Artery Bypass Graft Surgery for Left Main Coronary Artery Disease in Patients with and without Chronic Kidney Disease

Researchers

Presenter

  • Gennaro Giustino

Principal Investigators

  • Joseph Sabik

  • Bjorn Redfors

  • Milan Milojevic

  • Patrick Serruys

  • David Kandzari

  • Marie-Claude Morice

  • Anthony Gershlick

  • Philippe Genereux

  • Ovidiu Dressler

  • Zixuan Zhang

  • Roxana Mehran

  • A. Pieter Kappetein

  • Gregg Stone

Medical Centers

  • Piedmont Heart Institute, Atlanta, Georgia, United States

  • NYP-Columbia, New York, New York, United States

  • Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Hospital, New York, New York, United States

  • Cardiovascular Research Foundation, New York, New York, United States

  • Cardiovascular Research Foundation, Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States

  • Imperial College, London, United Kingdom

  • Department of Cardiothoracic Surgery, Erasmus University Medical Center, Rotterdam, Netherlands

  • University of Leicester, Leicester, UNITED KINGDOM

  • Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, United States

  • CERC, Massy, France

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

Locations

  • United States

  • United Kingdom

  • Netherlands

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

Disease

  • Left main disease

  • Chronic kidney disease

  • Renal disease

  • Stroke

Biomarkers

  • Creatinine

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved